Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 14 , ISSUE 4 ( July-August, 2022 ) > List of Articles

RESEARCH ARTICLE

Fetal Blood Sampling: Indications, Outcome and Complications

M Raksha, HC Sudha, Swagatha Mukherjee, Rekha Varadaraj, KV Malini

Citation Information : Raksha M, Sudha H, Mukherjee S, Varadaraj R, Malini K. Fetal Blood Sampling: Indications, Outcome and Complications. J South Asian Feder Obs Gynae 2022; 14 (4):453-457.

DOI: 10.5005/jp-journals-10006-2077

License: CC BY-NC 4.0

Published Online: 22-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract
PDF Share
  1. Kamini A Rao. Introduction to Genetics and Fetal Medicine, FOGSI Publications. 1996;73–75.
  2. Nicolaides KH, Soothill PW, Rodeck CH, et al. Rh disease: Intravascular fetal blood transfusion by cordocentesis. Fetal Ther 1986;1(4):185–192. DOI: 10.1159/000262267.
  3. Sarno AP Jr, Wilson RD. Fetal cardiocentesis: a review of indications, risks, applications and technique. Fetal Diagn Ther 2008;23(3):237–244. DOI: 10.1159/000116748.
  4. Antsalkis AI, Papantoniou NE, Mesogitis SA, et al. Cardiocentesis: an alternative method of fetal blood sampling for the prenatal diagnosis of hemoglobinopathies. Obstet Gynecol 1992;79(4):630–633. PMID: 1553190.
  5. Nicholini U, Santolaya J, Ojo OE. The fetal intrahepatic umbilical vein as an alternative to cord needling for prenatal diagnosis and therapy. Prenat Diagn 1988;665–671. DOI: 10.1002/pd.1970080906.
  6. Nicholini U, Nicholaidis P, Fisk NM, et al. Fetal blood sampling from the intrahepatic vein: analysis of safety and clinical experience with 214 procedures. Obstet Gynecol 1990;76(1):47–53. PMID: 1972789.
  7. Tongsong T, Wanapirak C, Kunavikatikul C, et al. Fetal loss rate associated with cordocentesis at midgestation. Am J Obstet Gynecol 2001;184(4):719–723. DOI: 10.1067/mob.2001.111716.
  8. Leung WC, Lau ET, Lau WL, et al. Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide?. Hong Kong Med J 2008;14(1):6–13. PMID: 18239237.
  9. Randolph LM. Prenatal cytogenetics. In: Gersen SL, Keagle MB (eds.). The Principles of Clinical Cytogenetics. Totowa, NJ: Humana Press Inc. 2005:267–321.
  10. Haddow JE, Palomaki GE, Knight GJ, et al. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 1994;330(16):1114–1118. DOI: 10.1056/NEJM199404213301603.
  11. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327(9):588–593. DOI: 10.1056/NEJM199208273270902.
  12. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening for Downs syndrome. Prenat Diagn 1997;17(9):821–829. PMID: 9316126.
  13. Summers AM, Langlois S, Wyatt P, et al. Prenatal screening for fetal aneuploidy. J Obstet Gynaecol Can 2007;29(2):146–161. DOI: 10.1016/S1701-2163(16)32379-9.
  14. Leivo T, Tuominen R, Saari-Kemppainen A, et al. Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial. Ultrasound Obstet Gynecol 1996;7(5):309–314. DOI: 10.1046/j.1469-0705.1996.07050309.x.
  15. Van den Hof MC, Wilson RD, Diagnostic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada. Fetal soft markers in obstetric ultrasound. J Obstet Gynaecol Can 2005;27(6):592–636.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.